Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2025
|
Bryan K Phillips Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,076
+35.33%
|
-
|
|
Feb 13
2025
|
Richard Buchholz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,076
+13.45%
|
-
|
|
Feb 13
2025
|
Carlton Weatherby Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,076
+40.5%
|
-
|
|
Feb 13
2025
|
Timothy P. Herbert CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
16,029
+39.1%
|
-
|
|
Feb 13
2025
|
John Rondoni Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,076
+24.67%
|
-
|
|
Feb 13
2025
|
Melissa Mann Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,076
+38.05%
|
-
|
|
Feb 13
2025
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
25,584
-13.59%
|
$4,681,872
$183.26 P/Share
|
|
Feb 13
2025
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+43.22%
|
$1,675,000
$67.63 P/Share
|
|
Feb 13
2025
|
Randy Ban Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,076
+39.29%
|
-
|
|
Feb 11
2025
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
583
-5.3%
|
$99,110
$170.49 P/Share
|
|
Feb 09
2025
|
Bryan K Phillips Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-6.27%
|
$51,324
$182.15 P/Share
|
|
Feb 09
2025
|
Richard Buchholz Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
314
-1.13%
|
$57,148
$182.15 P/Share
|
|
Feb 09
2025
|
Carlton Weatherby Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-11.62%
|
$56,966
$182.15 P/Share
|
|
Feb 09
2025
|
Timothy P. Herbert CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
896
-9.11%
|
$163,072
$182.15 P/Share
|
|
Feb 09
2025
|
Randy Ban Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
314
-10.19%
|
$57,148
$182.15 P/Share
|
|
Feb 09
2025
|
John Rondoni Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
315
-2.78%
|
$57,330
$182.15 P/Share
|
|
Jan 29
2025
|
Bryan K Phillips Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-4.34%
|
$38,556
$189.99 P/Share
|
|
Jan 15
2025
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+3.0%
|
$24,112
$176.33 P/Share
|
|
Jan 15
2025
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.39%
|
$14,256
$176.33 P/Share
|
|
Jan 15
2025
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
80
+3.37%
|
$14,080
$176.33 P/Share
|
|
Jan 15
2025
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
92
+3.43%
|
$16,192
$176.33 P/Share
|
|
Jan 07
2025
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
58
-0.51%
|
$12,470
$215.0 P/Share
|
|
Dec 20
2024
|
Timothy P. Herbert CEO and President |
SELL
Other acquisition or disposition
|
Indirect |
61,770
-34.43%
|
-
|
|
Nov 01
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,703
-12.68%
|
$1,688,382
$194.53 P/Share
|
|
Nov 01
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,703
+18.96%
|
$487,368
$56.58 P/Share
|
|
Oct 14
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
115
+2.61%
|
$24,150
$210.46 P/Share
|
|
Oct 14
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+3.45%
|
$16,590
$210.46 P/Share
|
|
Oct 14
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.33%
|
$14,280
$210.46 P/Share
|
|
Oct 14
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+2.99%
|
$16,170
$210.46 P/Share
|
|
Sep 09
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
31
-0.27%
|
$6,665
$215.0 P/Share
|
|
Sep 09
2024
|
Shawn Mc Cormick Director |
SELL
Open market or private sale
|
Direct |
800
-3.34%
|
$176,000
$220.0 P/Share
|
|
Aug 22
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,000
-16.18%
|
$945,000
$189.6 P/Share
|
|
Aug 22
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.39%
|
$355,000
$71.0 P/Share
|
|
Aug 16
2024
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
4,861
-25.9%
|
$913,868
$188.47 P/Share
|
|
Aug 16
2024
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,861
+38.04%
|
$204,162
$42.15 P/Share
|
|
Aug 15
2024
|
Randy Ban Officer |
SELL
Open market or private sale
|
Direct |
16,139
-22.8%
|
$3,098,688
$192.1 P/Share
|
|
Aug 15
2024
|
Randy Ban Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,139
+45.68%
|
$677,838
$42.15 P/Share
|
|
Aug 14
2024
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,537
+26.29%
|
$0
$0.94 P/Share
|
|
Jul 31
2024
|
Melissa Mann Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,190
+50.0%
|
-
|
|
Jul 15
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+4.61%
|
$16,146
$138.58 P/Share
|
|
Jul 15
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
154
+3.56%
|
$21,252
$138.58 P/Share
|
|
Jul 15
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+1.48%
|
$4,416
$138.58 P/Share
|
|
Jul 15
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
103
+0.5%
|
$14,214
$138.58 P/Share
|
|
May 31
2024
|
Timothy P. Herbert CEO and President |
SELL
Bona fide gift
|
Indirect |
3,000
-2.59%
|
-
|
|
May 29
2024
|
Charisse Y Sparks Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
64
-1.73%
|
-
|
|
May 10
2024
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+13.96%
|
$0
$0.94 P/Share
|
|
May 02
2024
|
Cynthia Burks Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+34.08%
|
-
|
|
May 02
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+15.12%
|
-
|
|
May 02
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+3.41%
|
-
|
|
May 02
2024
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+3.24%
|
-
|